SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-013041
Filing Date
2021-06-28
Accepted
2021-06-28 16:03:13
Documents
15
Period of Report
2021-06-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K espr-20210628.htm   iXBRL 8-K 44096
2 EX-10.1 ex101cmoemploymentcontract.htm EX-10.1 81104
3 EX-99.1 ex991cmohirepressrelease.htm EX-99.1 11646
7 tm2026634d1_ex99-1img001a01.jpg GRAPHIC 5932
  Complete submission text file 0001628280-21-013041.txt   312616

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20210628.xsd EX-101.SCH 1927
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20210628_lab.xml EX-101.LAB 24993
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20210628_pre.xml EX-101.PRE 13202
8 EXTRACTED XBRL INSTANCE DOCUMENT espr-20210628_htm.xml XML 11308
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 211053316
SIC: 2834 Pharmaceutical Preparations